20/07/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

20/07/2024

Jul 20, 2024, 11:37 | Blog
Mark Lewis: No specialist practices successfully in a vacuum
Mark Lewis shared Michael Misialek's, Associate Chair of Pathology at Newton-Wellesley Hospital, post on X,…
Jul 20, 2024, 11:34 | Blog
Abhishek D. Garg: TIM3+VISTA+ macrophage subset that mediates resistance to anticancer immunotherapy and chemotherapy
Abhishek D. Garg, Head of Laboratory of Cell Stress and Immunity (CSI) at KU Leuven,…
Jul 20, 2024, 11:34 | Blog
Supriya Peshin received a Young investigator Scholarship for the SOHO 2024
Supriya Peshin, Internal Medicine Resident Physician at Ballad Health, shared a post on X: ''I…
Jul 20, 2024, 11:31 | Blog
Advanced Oncoplastic Breast Surgery Hands On Course at SSO 2025
Abhishek Chatterjee, Professor of Surgery at Tufts Medical Center, shared on X:       …
Jul 20, 2024, 11:28 | Blog
Navneet Kaur: Years of dedication and hard work have led to this moment
Navneet Kaur, Resident at North Alabama Medical Center, shared a post on X: ''AAMC ID:…
Jul 20, 2024, 11:24 | Blog
Steven Marshall: Attending an evening with The Institute of Cancer Research on research regarding Sarcoma
Steven Marshall, CEO and Co-Founder of RISKGRID, shared a post by Sally Williams, Senior Philanthropy…
Jul 20, 2024, 11:18 | Blog
Jen Lovick: Excited to see all of the research being presented at AAPM2024
Jen Lovick, Executive Editor of Technology in Cancer Research and Treatment at Sage, shared a post…
Jul 20, 2024, 11:15 | Career
John McManus is the new St. Baldrick’s Chair of the Board
St. Baldrick's Foundation shared a post on LinkedIn:   . "Breaking news! Join us in welcoming…
Jul 20, 2024, 11:03 | Blog
Thejus Jayakrishnan: Host-microbiome interactions in early vs average-onset CRC
Thejus Jayakrishnan, Hematology/Oncology Fellow at Cleveland Clinic, shared a post on X: ''Publication alert.  Multi-omics…
Jul 20, 2024, 11:01 | Insight
Paolo Tarantino: Thanks to ESMO for featuring our 5-year analysis of the ATEMPT randomized phase 3 trial
Paolo Tarantino shared a post on LinkedIn about a paper titled "Adjuvant Trastuzumab Emtansine Versus…
All: 89 Posts: 61 - 70
Special Coverage